Low-dosage clonidine (Dixarit) in menopausal flushing.
Results of an open evaluation of the therapy with low-dosage clonidine (Dixarit) in a series of 20 patients with symptoms of menopausal flushing are presented. Twelve of the 17 patients who completed the 12-week trial noted an improvement in their condition: this improvement was marked in eight patients. The greatest improvement was noted in the perimenopausal group of women whose dosage requirement was 25 microgram three times a day. Postmenopausal women tended to be more refractory to the therapy and required larger dosages for the relief of symptoms.
D002979:Climacteric; D003000:Clonidine / Q000008:administration & dosage* / Q000627:therapeutic use; D005145:Face / Q000098:blood supply*; D005260:Female; D006801:Humans; D008875:Middle Aged
D003000:Clonidine